New Finger Prick Blood Test Promises Accessible Alzheimer's Detection

**Breaking new ground in Alzheimer's detection**, a European study led by the **University of Gothenburg** introduces an innovative finger prick blood test. Utilizing a special card that separates plasma from blood cells, this test offers a simpler, more accessible alternative to traditional venous blood sampling. **Key to its development** has been the adaptation of biomarkers, initially tested in cerebrospinal fluid, and now validated with superficial finger vessel samples. The test's effectiveness was demonstrated with 203 participants across five European memory clinics, with findings suggesting it performs comparably to traditional methods. Presented at the CTAD conference in Madrid by **Hanna Huber**, the test promises increased accessibility, especially in regions lacking sophisticated infrastructure. A forthcoming study aims to ascertain the feasibility of self-administration, potentially eliminating the need for healthcare personnel during sample collection. These advancements coincide with the emergence of new Alzheimer's treatments, underscoring the importance of **early detection**. Nevertheless, the WHO's current stance against broad Alzheimer's screening precludes its use as a general screening tool. This innovation could pave the way for **new research** into Alzheimer's genetics and global prevalence.